Article
Survival After Transplantation in Patients With Mutations Other Than Val30Met: Extracts From the FAP World Transplant Registry.
Transplantation - 1 Feb 2016
Suhr Ole B, Larsson Marie, Ericzon Bo-Göran, Wilczek Henryk E
Abstract excerpt
BACKGROUND: Liver transplantation (LTx) has been performed for hereditary transthyretin amyloidosis (ATTR) since 1990. Outcomes for a relatively large series of LTx ATTR patients with the Val30Met (mutation are available, but for non-Val30Met patients, only a few reports with a small number of patients exist. Here, we present outcomes for non-Val30Met ATTR patients after LTx, as reported to the Familial Amyloid...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
